Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Faculty Members have conducted research related to the A Randomized, Double-Blind, Phase Iii, Non-Inferiority Clinical Trial Comparing the Efficacy and Safety of Ta4415v (A Proposed Trastuzumab Biosimilar) and Herceptin (Trastuzumab Reference Product) in Her2-Positive Early-Stage Breast Cancer Patients
Kasra Kolahdouzan
Kasra Kolahdouzan

Assistant Professor of Radiation Oncology

Imam Khomeini Hospital Complex

Tehran University of Medical Sciences

All Documents
8. In Reply to Li Et Al., International Journal of Radiation Oncology Biology Physics (2023)
11. Low-Dose Whole Lung Irradiation for Treatment of Covid-19 Pneumonia: A Systematic Review and Meta-Analysis, International Journal of Radiation Oncology Biology Physics (2022)